AIMC Topic: Drug Discovery

Clear Filters Showing 61 to 70 of 1689 articles

MolAgent: Biomolecular Property Estimation in the Agentic Era.

Journal of chemical information and modeling
The advent of agentic AI systems is leading to significant transformations across scientific and technological domains. Advances in large language models (LLMs), reasoning capabilities, and integration with external tools have ushered in a new era wh...

A generalizable deep learning framework for structure-based protein-ligand affinity ranking.

Proceedings of the National Academy of Sciences of the United States of America
Rapid and accurate estimation of protein-ligand binding affinities is crucial for early-stage drug discovery, yet hindered by a trade-off between the accuracy of gold-standard physics-based methods and the speed of simpler empirical scoring functions...

BiMA-DTI: a bidirectional Mamba-Attention hybrid framework for enhanced drug-target interaction prediction.

BMC biology
BACKGROUND: Predicting drug-target interactions (DTIs) is essential for accelerating drug discovery, yet traditional experimental methods are time-consuming and costly. Computational approaches, especially those using machine learning and deep learni...

Metabolite Identification Data in Drug Discovery, Part 1: Data Generation and Trend Analysis.

Molecular pharmaceutics
In drug discovery, metabolite identification data are used to identify metabolic soft spots in research molecules to facilitate reduced metabolism in subsequently designed compounds. In addition, knowledge about exact metabolite structures enables th...

Ensemble techniques for predictive modeling of leishmanial activity via molecular fingerprints.

BMC medical informatics and decision making
BACKGROUND: Leishmaniasis, a neglected tropical disease caused by Leishmania protozoan parasites and transmitted by sandflies, poses a significant global health challenge, especially in resource-limited environments. The life cycle of the parasite in...

Accelerated Discovery of : A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell Malignancies.

Journal of medicinal chemistry
MALT1 is a key component of the CARD11-BCL10-MALT1 (CBM) complex downstream from BTK on the B-cell receptor signaling pathway. It is a key mediator of NF-κB signaling and considered a potential therapeutic target for several subtypes of non-Hodgkin's...

AI-driven drug discovery using a context-aware hybrid model to optimize drug-target interactions.

Scientific reports
Drug discovery is a challenging and resource-intensive process characterized by high costs, prolonged development timelines, and regulatory hurdles in the pharmaceutical sector. AI-driven recommendation systems have emerged as an effective approach t...

A generative framework for enhancing drug target interaction prediction in drug discovery.

Scientific reports
In silico drug-target interaction (DTI) prediction plays a key role in accelerating drug discovery and understanding molecular mechanisms. Traditional methods often struggle with the complexity and scale of biochemical data, thus limiting prediction ...

FragOPT: An ML-Driven Computational Workflow for Rational Fragments Optimization Toward Lead Compounds.

Journal of chemical information and modeling
Advances in machine learning (ML) offer significant potential to accelerate drug discovery. Although mathematical modeling and ML have become crucial in predicting drug-target interactions and properties, the complexity of chemical space and the "bla...

On Free Energy Calculations in Drug Discovery.

Accounts of chemical research
ConspectusThis Account discusses recent progress and challenges in binding free energy computations, focusing on two classes of enhanced sampling techniques: alchemical transformations and path-based methods. Binding free energy is a crucial metric i...